More News

03 Jan 2019 Takeda Announces Multiple Cell Therapy Collaborations to Advance the Company’s Novel Immuno-Oncology Portfolio
03 Jan 2019 Vertex and Arbor Biotechnologies Establish Collaboration to Discover Novel Proteins to Advance Discovery of Gene-Editing Therapies
03 Jan 2019 Merck Exercises Option for NGM Bio’s Investigational Insulin Sensitizer, NGM313, for the Treatment of NASH and Type 2 Diabetes
03 Jan 2019 Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company
03 Jan 2019 Jazz Pharmaceuticals and Codiak BioSciences Announce Strategic Collaboration to Research, Develop and Commercialize Engineered Exosomes to Create Therapies for Hard-to-Treat Cancers
03 Jan 2019 APRINOIA Therapeutics Licenses Tau PET Imaging Tracer APN-1607 to Celgene
03 Jan 2019 HJB Merges with MabSpace Biosciences to Form Transcenta Holding, a Fully Integrated Leading Global Biotherapeutics Company
03 Jan 2019 Merus Announces Strategic Collaboration with Betta Pharmaceuticals to Develop and Commercialize MCLA-129 in China
03 Jan 2019 Acer Therapeutics Announces In-license of Osanetant from Sanofi
27 Dec 2018 Opiant Pharmaceuticals Licenses Novel CB-1 Receptor Antagonist for Treatment of Acute Cannabinoid Overdose from Sanofi
26 Dec 2018 Lupin and AbbVie Announce Partnership to Develop and Commercialize Novel Oncology Drug to Treat Hematological Cancers
22 Dec 2018 Alcyone Lifesciences Announces Broad Strategic Collaboration with Roche in the Field of Intrathecal Therapies
22 Dec 2018 Windtree Therapeutics and CVie Therapeutics Announce Merger to Create a Global Acute Care Company Targeting Cardiovascular and Respiratory Diseases
21 Dec 2018 Xynomic Pharma Acquires Global Exclusive Rights to Phase 2 Ready mTORC1/2 Inhibitor from Boehringer Ingelheim
20 Dec 2018 Roivant Sciences and Daiichi Sankyo Enter into Broad Pipeline Partnership
20 Dec 2018 Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon
20 Dec 2018 Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier Global Consumer Healthcare Company
20 Dec 2018 Gilead and Agenus Enter Into Collaboration to Develop Immuno-Oncology Therapies
20 Dec 2018 Ayala Pharmaceuticals Signs Deal to Develop and Commercialize AL102 in Combination with BCMA Targeting Agents in Multiple Myeloma
20 Dec 2018 Tetra Discovery Partners and Shionogi & Co., Ltd. Collaborate on BPN14770 Development and Commercialization
20 Dec 2018 Gilead Sciences and Scholar Rock Announce Strategic Collaboration to Develop Novel Therapies for Fibrotic Diseases
20 Dec 2018 Akaal Pharma Pty Ltd Announces Licensing Agreement for its First-in-Class, Topical Spingosine-1-Phosphate-1 (S1P1) Receptor Modulator for Atopic Dermatitis and Psoriasis
20 Dec 2018 X-Chem enters strategic collaboration with Bristol-Myers Squibb
19 Dec 2018 Pyramid Biosciences Announces Exclusive Global License of AstraZeneca TRK Program for Dermatology and Inflammatory Diseases
19 Dec 2018 Kineta Enters Research Collaboration and License Agreement with Pfizer to Develop New Cancer Immunotherapies

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up